There are 3 papers on Sybil in aging research: 1 observational study in people.
3 papers study it10 more mention it2 findings
7 new papers in 30 daysSee all 13 papers on Sybil
“Sybil's overall area under the curve (AUC) ranged from 0.819 to 0.912; while its 2-year AUC for Lung-RADS 1 and 2 cases was 0.746.”
- Humans1
- In silico2
Effects
1Screening interval
upin silico1+34% negative screens extended to biennial screening, with no delayed cancers
1 study
Screening interval
upin silico1+34% negative screens extended to biennial screening, with no delayed cancers
Sybil increases screening interval in silico (Screening interval extension simulation calibrated for a 30% shift to biennial screening) (33.8% of negative screens extended to biennial screening, with no delayed cancers).
“33.8% of negative screens in our data being safely extended using Sybil, with no delayed cancers.”
In silicoScreening interval extension simulation calibrated for a 30% shift to biennial screeninglung
medRxivPreprint
Associations
1Lung cancer
upin humans1
1 study
Lung cancer
upin humans1
Sybil predicts lung cancer in humans (Tertiary safety-net hospital lung cancer screening cohort) (Overall AUC 0.819–0.912; 2-year AUC 0.746 in Lung-RADS 1 and 2 cases).
“Sybil's overall area under the curve (AUC) ranged from 0.819 to 0.912; while its 2-year AUC for Lung-RADS 1 and 2 cases was 0.746.”
HumansTertiary safety-net hospital lung cancer screening cohortlungn = 3,120
medRxivPreprint